Bajramović J J, Plomp A C, Goes A v, Koevoets C, Newcombe J, Cuzner M L, van Noort J M
Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands.
J Immunol. 2000 Apr 15;164(8):4359-66. doi: 10.4049/jimmunol.164.8.4359.
In the development of multiple sclerosis (MS), (re)activation of infiltrating T cells by myelin-derived Ags is considered to be a crucial step. Previously, alpha B-crystallin has been shown to be an important myelin Ag to human T cells. Since alpha B-crystallin is an intracellular heat shock protein, the question arises at what stage, if any, during lesional development in MS this Ag becomes available for CD4+ T cells. In 3 of 10 active MS lesions, alpha B-crystallin could be detected inside phagocytic vesicles of perivascular macrophages, colocalizing with myelin basic protein and myelin oligodendrocyte glycoprotein (MOG). Although the detectability of MOG in phagosomes is considered as a marker for very recent demyelination, MOG was detected in more macrophages and in more lesions than alpha B-crystallin. The disappearance of alpha B-crystallin from macrophages even before MOG was confirmed by in vitro studies; within 6 h after myelin-uptake alpha B-crystallin disappears from the phagosomes. Alpha B-crystallin-containing macrophages colocalized with infiltrating T cells and they were characterized by expression of MHC class II, CD40, and CD80. To examine functional presentation of myelin Ags to T cells, purified macrophages were pulsed in vitro with whole myelin membranes. These macrophages activated both myelin-primed and alpha B-crystallin-primed T cells in terms of proliferation and IFN-gamma secretion. In addition, alpha B-crystallin-pulsed macrophages activated myelin-primed T cells to the same extent as myelin-pulsed macrophages, whereas myelin basic protein-pulsed macrophages triggered no response at all. These data indicate that, in active MS lesions, alpha B-crystallin is available for functional presentation to T cells early during inflammatory demyelination.
在多发性硬化症(MS)的发展过程中,髓鞘来源的抗原激活浸润性T细胞被认为是关键步骤。此前,αB晶状体蛋白已被证明是对人类T细胞重要的髓鞘抗原。由于αB晶状体蛋白是一种细胞内热休克蛋白,因此出现了一个问题:在MS病变发展过程中的哪个阶段(如果有的话),这种抗原会可供CD4 + T细胞利用。在10个活动性MS病变中的3个中,可在血管周围巨噬细胞的吞噬泡内检测到αB晶状体蛋白,其与髓鞘碱性蛋白和髓鞘少突胶质细胞糖蛋白(MOG)共定位。尽管吞噬体中MOG的可检测性被视为近期脱髓鞘的标志物,但在更多巨噬细胞和更多病变中检测到的MOG比αB晶状体蛋白多。体外研究证实,甚至在MOG之前,巨噬细胞中的αB晶状体蛋白就已消失;摄取髓鞘后6小时内,αB晶状体蛋白从吞噬体中消失。含αB晶状体蛋白的巨噬细胞与浸润性T细胞共定位,其特征是表达MHC II类分子、CD40和CD80。为了研究髓鞘抗原向T细胞的功能性呈递,用全髓鞘膜在体外对纯化的巨噬细胞进行脉冲处理。这些巨噬细胞在增殖和IFN-γ分泌方面激活了髓鞘致敏和αB晶状体蛋白致敏的T细胞。此外,αB晶状体蛋白脉冲处理的巨噬细胞激活髓鞘致敏T细胞的程度与髓鞘脉冲处理的巨噬细胞相同,而髓鞘碱性蛋白脉冲处理的巨噬细胞根本没有引发反应。这些数据表明,在活动性MS病变中,αB晶状体蛋白在炎症性脱髓鞘早期即可用于向T细胞进行功能性呈递。